Boombostic Health

Summary

In this conversation, Craig Hittle discusses the evolving nature of telemedicine, emphasizing that it should not be viewed merely as a transactional service. Instead, he advocates for a model that fosters long-term relationships between patients and healthcare providers, enhancing the overall quality of care delivered through digital platforms.

Takeaways

• Telemedicine is often misunderstood as purely transactional.
• The goal of telemedicine should be to build relationships.
• Long-term relationships with providers can improve patient care.
• Telemedicine can enhance accessibility to healthcare services.
• Establishing trust is crucial in telehealth interactions.
• Patients should feel connected to their providers through telemedicine.
• Digital health platforms can facilitate ongoing care.
• The future of healthcare includes a blend of in-person and virtual visits.
• Effective communication is key in telehealth.
• Telemedicine can lead to better health outcomes when used correctly.

Chapters

00:00 Introduction to Health Tap and Primary Care Innovations
04:16 The State of Primary Care in America
05:08 The Rise of Telemedicine and Its Impact
09:30 Telemedicine: A Shift in Patient Care Dynamics
12:39 Understanding the Durbin Report and Its Implications
15:35 Chronic Condition Management and Telehealth
17:58 The Role of AI in Enhancing Patient Care
21:11 Genomic Information in Primary Care
24:16 The Future of Telemedicine and Patient Relationships
28:26 Challenges and Opportunities for Primary Care Doctors
34:08 Value-Based Care: Aligning Incentives for Better Health

Every year in the U.S., 275,000 people die because of medication mismanagement — a failure that drains $528 billion annually from our $5 trillion healthcare system. It's healthcare's deadly hidden failure.

That's where DecisionRx comes in. Their coined Medication Therapy Optimization (MTO) approach goes far beyond Pharmacogenetics (PGx), combining AI-powered insights with pharmacist-led care to stop the guesswork, lower risk, and deliver results at scale.

In this episode, host Bradley Bostic sits down with Mike Tilton, Chief Growth Officer at DecisionRx, to unpack the problem and spotlight the fix that's delivering:

• 8–10% reduction in total healthcare costs

• 94% patient satisfaction

• Maximum savings with minimal abrasion

• Why $528B is being lost annually to preventable medication mismanagement.

• How DecisionRx's MTO model fixes the problem holistically — not just by swapping pills.

• Why ER visits, hospitalizations, and complications drive the real costs.

• Randall's story: from 18 prescriptions and $12K/month to a sustainable regimen that restored his health.

• How DecisionRx's shared-savings model makes adoption possible even for financially strapped health systems.

Medication mismanagement is killing us. DecisionRx has the fix.
👉 Learn more at decisionrx.com

Subscribe to Boombostic Health for bold conversations that expose healthcare's failures — and the solutions that can finally change it.

Summary
Pre-market clinical trials are essential — but they don't reflect how devices truly perform once they're in the real world. In this episode of Boombostic Health, host Bradley Bostic sits down with Dr. Amelia Hufford, Co-Founder and SVP of Clinical and Regulatory Science at 3Aware, to unpack why real-world data (RWD) is critical to the survival of medical devices — and why mindset, not science, may be the biggest barrier holding MedTech back.

Amelia shares her 20+ year journey in scientific and clinical research, including a decade in MedTech leading regulatory and clinical affairs. She explains how RWD fills the gaps left by clinical trials, supports post-market surveillance, uncovers off-label use, and even opens the door to label expansion — giving manufacturers faster, less costly ways to prove safety and effectiveness.

The conversation dives into the risks of ignoring RWD, the opportunities it creates for innovation and revenue, and how this shift could save one-third of devices currently at risk of disappearing from the market.

What You'll Learn in This Episode

• Why pre-market clinical trials don't fully reflect everyday device usage.

• How real-world data provides insights into broader and more diverse patient populations.

• Why manufacturers fear off-label data — and how it can actually unlock new markets.

• The importance of treating RWD studies with the same rigor as traditional clinical research.

• How RWD can accelerate innovation, improve patient outcomes, reduce costs, and support regulatory compliance.

Why It Matters
Without embracing real-world data, the MedTech industry risks losing critical devices — some of which save lives in high-stakes scenarios. By shifting mindset and using RWD with scientific rigor, manufacturers can not only ensure patient safety but also unlock growth opportunities, accelerate label expansion, and meet regulatory demands more efficiently.

Resources & Links

• Learn more about 3Aware

• Connect with Dr. Amelia Hufford on LinkedIn

• Follow Bradley Bostic on LinkedIn

• Subscribe on LinkedIn for weekly newsletter

Why is giving birth in the United States still so risky—especially for Black and Native American mothers? In this powerful episode of Boombostic Health, host Bradley Bostic sits down with Tiffany Hall, a nurse and maternal health expert who has spent decades on the frontlines of patient care and blood management. Tiffany exposes the hidden pregnancy risk no one is talking about: anemia.

Drawing from both clinical experience and hc1's MyBloodHealth technology, Tiffany explains how anemia silently drives up rates of hemorrhage, heart complications, postpartum depression, and even maternal death. And while anemia is often missed in early pregnancy (18% of women in the 1st trimester), it skyrockets to 80% by the 3rd trimester—when it's far harder to manage.

The conversation also dives into the stark racial disparities in maternal outcomes: Black and Native mothers die at a rate of 49.5 per 100,000 births, compared to 19 per 100,000 for white mothers. Tiffany unpacks how fragmented care, lack of early screening, and systemic inequities continue to put mothers and babies at risk—despite being preventable.

But it's not all grim. Tiffany also shares how HerCare powered by MyBloodHealth is giving providers the tools to proactively identify risk, streamline workflows, and deliver better outcomes for both moms and babies.

Guest: Tiffany Hall, Nurse and Director of cPBM Clinical Technology at hc1

• 📊 The shocking stats: anemia's rise from 18% in the 1st trimester to 80% by the 3rd

• ⚠️ How anemia fuels hemorrhage, cardiovascular problems, and postpartum depression

• ✊ Why Black and Native mothers face mortality rates more than 2X higher than white mothers

• 🧪 How lab-driven insights can flip care from reactive to proactive

• 💡 How HerCare simplifies provider workflows and closes dangerous gaps in maternal care

Every statistic in this episode represents mothers, babies, and families forever changed. Tiffany's message is clear: maternal deaths and injuries in the U.S. are preventable—but only if we address hidden risks early and make proactive care the standard.

Chapter Highlights:

00:00 – Intro & Guest

01:57 – Tiffany's Background

04:46 – Mothers & Babies at Risk

05:29 – Broken U.S. Care System

08:18 – 49.5 vs 19: The Disparity

10:09 – Hidden Risk: Anemia

11:57 – How HerCare Works

19:23 – Awareness & Policy Change 

22:07 – The Future of Maternal Care

27:56 – Closing & Takeaways

AI in healthcare isn't about robot doctors — it's about building billion-dollar businesses. In this episode of Boombostic Health, Bradley Bostic sits down with Nigel Ohrenstein, CEO of Diagnostic Robotics and veteran healthcare entrepreneur, to explore how agentic AI is quietly reshaping the $4T healthcare industry.

Nigel has taken companies from napkin sketch to multi-billion-dollar scale — most notably co-founding Lumeris and now leading Diagnostic Robotics. He shares what it really takes to scale in healthcare, why execution matters more than ideas, and how AI is transforming the 80/20 rule: shifting clinicians' time from endless paperwork back to patient care.

Together, they unpack:

• Why AI in healthcare isn't about replacing doctors — it's about unlocking billion-dollar impact.
• How Nigel scaled Lumeris into a multi-billion-dollar company and the lessons he carried forward. 
• The role of agentic AI in automating administrative tasks and enabling faster, cheaper, and higher-quality care.
• Why the next wave of healthcare innovation will be built by operators who understand both incentives and execution.
• The untold story of scaling companies in a $4T industry under massive pressure to change.

Chapters

00:00 Introduction to Diagnostic Robotics and Nigel's Journey

08:37 The Drive Behind Innovation in Healthcare

16:56 Understanding Agentic AI in Healthcare

25:31 AI in Healthcare: Streamlining Administrative Tasks

29:00 Transforming Patient Engagement and Care Quality

30:51 Lessons from John Doar: Execution and Preparation

36:50 The Role of Technology in Healthcare

46:13 Innovation Under Pressure: Opportunities in Healthcare

96% Accurate Cancer Detection — Without an Invasive Biopsy? The Breakthrough Test That Could Save Millions

What if detecting cancer was as simple as giving a urine sample? No needles. No surgery. No fear.

In this episode of Boombostic Health, host Bradley Bostic sits down with Curtiss McNair Jr., VP of Operations at PanGIA Biotech, to unpack one of the most groundbreaking medical innovations in decades: a urine test powered by AI that can detect multiple cancers with jaw-dropping accuracy.

But this conversation isn't just about the science. It's also about the leadership and vision needed to take innovations like this from the lab to real-world patients.

• The Breakthrough: How PanGIA's urine test achieves 96% sensitivity, 74% precision, and an 84% F1 score in early cancer detection.

• Why It Matters: 2 out of 3 biopsies for prostate and brain cancer come back benign. This test could eliminate unnecessary, invasive procedures.

• Global Impact: Why PanGIA launched first in India, and how cultural barriers to invasive exams are driving adoption.

• AI in Action: How artificial intelligence identifies subtle biomarker patterns invisible to the human eye.

• The Leadership Gap: Why building better healthcare depends not just on new technology, but on bold leaders willing to drive systemic change.

Cancer has touched nearly every family, and early detection is the single most powerful tool we have to save lives. This episode blends cutting-edge science, practical healthcare realities, and leadership wisdom that every innovator, clinician, and patient advocate needs to hear.

What does it really take to build and scale a healthcare company?

In this episode of Boombostic Health, Bradley Bostic sits down with Lee Shapiro—Managing Partner at 7wire Ventures, former President of Allscripts, and co-founder of Livongo—to talk about his journey from "recovering lawyer" to building one of the most successful companies in digital health.

Lee shares how he and Glenn Tullman grew Livongo into a public company and ultimately merged with Teladoc in a landmark $18.5 billion deal. He breaks down why healthcare innovation is never an overnight success, how to spot "Uber moments" in healthtech, and why solving consumer hassles is the future of care.

Whether you're an entrepreneur, investor, or operator, this conversation offers a masterclass on building meaningful healthcare businesses that last.

Key Moments

00:00 – Intro: Bradley Bostic welcomes Lee Shapiro of 7wire Ventures

01:40 – From lawyer to entrepreneur: Why Lee left law to build companies

05:20 – Allscripts and the early days of digital health

10:30 – The Livongo story: 6-year grind to IPO and $18.5B Teladoc merger 

13:50 – The B2B2C model in healthcare explained

15:20 – Consumer hassle mapping: Finding healthcare's "Uber moments"

17:20 – Value-based care & empowering the patient

19:40 – Scaling through M&A: The $620M Accolade–Transcarent deal 

25:30 – How 7wire Ventures supports portfolio founders beyond capital

29:20 – Doing well by doing good: Investing with purpose in healthcare

31:10 – Cubs or Sox? Lee's Chicago roots and final thoughts

Key Topics

• Digital health entrepreneurship
• Venture capital in healthcare 
• How Livongo scaled to an $18.5B deal with Teladoc 
• The future of value-based care 
• Consumer hassle mapping and patient empowerment
• Healthcare M&A and scaling strategies

What if women could know — years in advance — when perimenopause and menopause will begin?

In this episode of Boombostic Health, host Bradley Bostic talks with Nich Gentry and Dr. Lizellen La Follette of Life Ahead, a groundbreaking company combining ultrasound, personalized data, and validated science to give women a clear picture of their reproductive timeline.

You'll learn:

• Why ovarian aging is the "canary in the coal mine" for overall health.

• How early menopause prediction could transform bone health, cognitive health, and preventive care.

• The science behind Life Ahead's algorithm — and why it's a breakthrough for both patients and clinicians.

• Why women's health research has been historically underfunded and how that's changing.

• The entrepreneurial challenges of building a science-backed health tech company.

Whether you're in healthcare, innovation, or simply care about the future of women's health, this conversation will leave you inspired — and rethinking what's possible in preventive care.

Listen now to learn how data, science, and proactive healthcare can rewrite the future for millions of women.

00:00 – Why Proactive Healthcare Matters
Shifting from reactive to proactive care in women's health.

01:14 – Meet Life Ahead
Nich and Dr. Lizellen share their mission to close the women's health gap.

04:11 – Understanding Ovarian Aging
Why ovaries age faster than most organs and what it means for overall health.

08:16 – Perimenopause Explained
What it is, symptoms, and why timing matters.

10:11 – The Cost of Waiting
How early menopause prediction could save money and improve health outcomes.

12:41 – The Science Behind the Tool
From NSF funding to Yale mathematicians — the breakthrough research journey.

14:43 – The Startup Rollercoaster
Highs, lows, and challenges of building a new category in healthcare.

27:17 – WHOOP, Fitness, and Sleep
Why tracking recovery and lifestyle metrics is part of better healthcare.

30:17 – Looking Ahead
Envisioning the future of women's health through predictive technology.

Summary

Guest: Melissa Butterworth, CEO of Advanced Strategic Partners

Overview: Hospitals are under extreme financial pressure—but what if the answer to their budget woes is sitting right inside their own labs? 

In this eye-opening episode, Melissa Butterworth—who's led over $2.4 billion in lab transactions—joins Bradley to explore the growing trend of health systems divesting lab assets. Together, they unpack:

• Why hospitals are selling even profitable lab outreach operations
• How to accurately assess the real value of a lab business
• What happens post-sale—and how to unlock even more value with AI-powered lab insights.

Chapters: 

04:30 Melissa's story: from LabCorp exec to M&A powerhouse

07:20 Why lab outreach programs are being sold off—even with 40%+ margins

10:50 "Compressed value": What hospital labs are really worth to buyers like LabCorp or Quest

15:40 The rise of AI in lab-driven personalized medicine

17:45 Predicting Alzheimer's from routine labs? It's already happening.

17:55 The Role of Labs in Future Healthcare

Key Quote: 

"It's just as hard to play small as it is to play big. So why not go big?" – Bradley Bostic

In this episode, host Bradley Bostic sits down with healthcare innovator and author Jim Wallace to discuss how AI, wearables, genomics, and big data are transforming the way care is delivered. Wallace shares insights from his new book, Precision Medicine, AI, and the Science of Personalized Health Care, revealing why traditional models of care are falling short—and what's next.

What you'll learn:

• Why 53% of medications don't work as intended

• How social support increases patient survival by up to 50%

• Where healthcare investment is missing the mark

• What the Alice Walton School of Medicine is doing differently

• How AI is closing critical care gaps from anemia to cancer

Chapters

00:00 Introduction to Value-Based Care and AI
04:57 The Journey to Personalized Healthcare
11:12 AI's Role in Transforming Healthcare
18:25 The Importance of Preventive Medicine
25:49 Innovations in Medical Education
33:58 The Future of Healthcare and AI